{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:03:29Z","timestamp":1768554209520,"version":"3.49.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0096547","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T00:53:02Z","timestamp":1399337582000},"page":"e96547","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":51,"title":["Effect of Currently Approved Carriers and Adjuvants on the Pre-Clinical Efficacy of a Conjugate Vaccine against Oxycodone in Mice and Rats"],"prefix":"10.1371","volume":"9","author":[{"given":"Marco","family":"Pravetoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Vervacke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Distefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashli M.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Laudenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Pentel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,5,5]]},"reference":[{"key":"ref1","unstructured":"UNODC (2012) World Drug Report 2012."},{"key":"ref2","unstructured":"National Survey on Drug Use and Health: National Findings (2013)"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"IA Binswanger","year":"2013","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2011.281","article-title":"Vaccines against drug abuse","volume":"91","author":"XY Shen","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e76557","DOI":"10.1371\/journal.pone.0076557","article-title":"Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in mice","volume":"8","author":"DC Pryde","year":"2013","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Cai X, Whitfield T, Moreno AY, Grant Y, Hixon MS, <etal>et al<\/etal>.. (2013) Probing the Effects of Hapten Stability on Cocaine Vaccine Immunogenicity. Mol Pharm.","DOI":"10.1021\/mp400214w"},{"key":"ref7","article-title":"Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alum","author":"SH de Villiers","year":"2013","journal-title":"Vaccine"},{"key":"ref8","article-title":"A novel and efficient nicotine vaccine using nano-lipoplex as a delivery vehicle","volume":"10","author":"Y Hu","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.intimp.2013.03.021","article-title":"Enhancing immunogenicity of a 3&apos;aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates","volume":"16","author":"MJ McCluskie","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bmcl.2012.12.048","article-title":"Enhancing nicotine vaccine immunogenicity with liposomes","volume":"23","author":"JW Lockner","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.vaccine.2012.10.069","article-title":"High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants","volume":"31","author":"X Chen","year":"2012","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1016\/j.vaccine.2013.04.027","article-title":"Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs","volume":"31","author":"GR Matyas","year":"2013","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bcp.2011.11.004","article-title":"Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities","volume":"83","author":"M Pravetoni","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/jm3013745","article-title":"Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens","volume":"56","author":"M Pravetoni","year":"2013","journal-title":"J Med Chem"},{"key":"ref15","article-title":"An oxycodone conjugate vaccine elicits oxycodone-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia","author":"M Pravetoni","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1007\/BF01470995","article-title":"Keyhole limpet hemocyanin conjugate vaccines against cancer: the Memorial Sloan Kettering experience","volume":"127 Suppl 2","author":"C Musselli","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1126\/science.1201730","article-title":"Different B cell populations mediate early and late memory during an endogenous immune response","volume":"331","author":"KA Pape","year":"2011","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1084\/jem.20112272","article-title":"Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen","volume":"209","author":"JJ Taylor","year":"2012","journal-title":"J Exp Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20111696","article-title":"A germinal center-independent pathway generates unswitched memory B cells early in the primary response","volume":"209","author":"JJ Taylor","year":"2012","journal-title":"J Exp Med"},{"key":"ref20","article-title":"Hapten-specific naive B cells are biomarkers of vaccine efficacy against drugs of abuse","author":"JJ Taylor","year":"2014","journal-title":"J Immunol Methods"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e38329","DOI":"10.1371\/journal.pone.0038329","article-title":"Immunogenicity of a promiscuous T cell epitope peptide based conjugate vaccine against benzo[a]pyrene: redirecting antibodies to the hapten","volume":"7","author":"MT Schellenberger","year":"2012","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1124\/pr.109.001073","article-title":"Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer","volume":"61","author":"LA O'Neill","year":"2009","journal-title":"Pharmacol Rev"},{"key":"ref23","article-title":"T-cell-dependent antibody responses in the rat: Forms and sources of keyhole limpet hemocyanin matter","author":"H Lebrec","year":"2013","journal-title":"J Immunotoxicol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","article-title":"A novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents","volume":"24","author":"B Anton","year":"2006","journal-title":"Vaccine"},{"key":"ref25","article-title":"Liposomes containing monophosphoryl lipid A: A potent adjuvant system for inducing antibodies to heroin hapten analogs","author":"GR Matyas","year":"2013","journal-title":"Vaccine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrd3012","article-title":"Carbohydrate vaccines: developing sweet solutions to sticky situations?","volume":"9","author":"RD Astronomo","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4161\/hv.2941","article-title":"Cancer vaccines targeting carbohydrate antigens","volume":"2","author":"PO Livingston","year":"2006","journal-title":"Hum Vaccin"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1634\/theoncologist.2010-0307","article-title":"Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer","volume":"16","author":"D Miles","year":"2011","journal-title":"Oncologist"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1158\/1078-0432.CCR-06-2189","article-title":"Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21","volume":"13","author":"TA Gilewski","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","article-title":"Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial","volume":"66","author":"BA Martell","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0264-410X(01)00425-X","article-title":"Human therapeutic cocaine vaccine: safety and immunogenicity","volume":"20","author":"TR Kosten","year":"2002","journal-title":"Vaccine"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/clpt.2010.317","article-title":"Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic","volume":"89","author":"DK Hatsukami","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.clpt.2005.08.007","article-title":"Safety and immunogenicity of a nicotine conjugate vaccine in current smokers","volume":"78","author":"DK Hatsukami","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e2547","DOI":"10.1371\/journal.pone.0002547","article-title":"A vaccine against nicotine for smoking cessation: a randomized controlled trial","volume":"3","author":"J Cornuz","year":"2008","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/eji.200526285","article-title":"A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity","volume":"35","author":"P Maurer","year":"2005","journal-title":"Eur J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1567-5769(02)00260-6","article-title":"Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant","volume":"3","author":"SD Sanderson","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"10776","DOI":"10.1021\/jm301262z","article-title":"Investigating the effects of a hydrolytically stable hapten and a Th1 adjuvant on heroin vaccine performance","volume":"55","author":"PT Bremer","year":"2012","journal-title":"J Med Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1073\/pnas.1200130109","article-title":"Morphine activates neuroinflammation in a manner parallel to endotoxin","volume":"109","author":"X Wang","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1152\/physrev.1998.78.4.1131","article-title":"Using knockout and transgenic mice to study neurophysiology and behavior","volume":"78","author":"MR Picciotto","year":"1998","journal-title":"Physiol Rev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/infdis\/jis182","article-title":"Gene polymorphism in toll-like receptor 4: effect on antibody production and persistence after acellular pertussis vaccination during adolescence","volume":"205","author":"K Grondahl-Yli-Hannuksela","year":"2012","journal-title":"J Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e3665","DOI":"10.1371\/journal.pone.0003665","article-title":"Association of interacting genes in the toll-like receptor signaling pathway and the antibody response to pertussis vaccination","volume":"3","author":"TG Kimman","year":"2008","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1473-3099(05)70023-2","article-title":"Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease","volume":"5","author":"NW Schroder","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4049\/jimmunol.1201047","article-title":"Reduced surface expression of TLR4 by a V254I point mutation accounts for the low lipopolysaccharide responder phenotype of BALB\/c B cells","volume":"190","author":"H Tsukamoto","year":"2013","journal-title":"J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/intimm\/dxs084","article-title":"Human TLR4 polymorphism D299G\/T399I alters TLR4\/MD-2 conformation and response to a weak ligand monophosphoryl lipid A","volume":"25","author":"N Yamakawa","year":"2013","journal-title":"Int Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0096547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T06:29:31Z","timestamp":1565418571000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0096547"}},"subtitle":[],"editor":[{"given":"Valerie A.","family":"Ferro","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,5]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0096547","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,5]]}}}